D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$549M |
| 2 |
CVS Health
CVS
|
+$537M |
| 3 |
Meta Platforms (Facebook)
META
|
+$515M |
| 4 |
McDonald's
MCD
|
+$386M |
| 5 |
Home Depot
HD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$475M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$442M |
| 3 |
AGN
Allergan plc
AGN
|
+$435M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$369M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.4% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Technology | 10.06% |
| 4 | Financials | 9.8% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCAP
2526
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $790K | ﹤0.01% |
125,020
+9,136
| +8% | +$60.9K |
|
2527
Travere Therapeutics
TVTX
$5.27B
| $787K | ﹤0.01% |
44,186
+16,577
| +60% | +$268K |
|
2528
CALL
NXP Semiconductors
NXPI
$67.6B
| $783K | ﹤0.01% |
10,000
| – | – |
|
|
GIFI
2529
DELISTED
Gulf Island Fabrication
GIFI
| $781K | ﹤0.01% |
112,482
+38,587
| +52% | +$276K |
|
2530
Lattice Semiconductor
LSCC
$16.8B
| $780K | ﹤0.01% |
145,825
-143,479
| -50% | -$800K |
|
2531
COPT Defense Properties
CDP
$4.34B
| $777K | ﹤0.01% |
26,290
+3,540
| +16% | +$95.1K |
|
2532
Gladstone Investment Corp
GAIN
$648M
| $777K | ﹤0.01% |
108,516
+46,220
| +74% | +$322K |
|
2533
Selective Insurance
SIGI
$5.53B
| $775K | ﹤0.01% |
20,275
-31,164
| -61% | -$1.12M |
|
2534
PUT
HCA Healthcare
HCA
$86.4B
| $770K | ﹤0.01% |
10,000
| – | – |
|
2535
AZZ Inc
AZZ
$4.47B
| $769K | ﹤0.01% |
+12,818
| New | +$733K |
|
2536
Renasant Corp
RNST
$4B
| $769K | ﹤0.01% |
23,779
+6,992
| +42% | +$233K |
|
|
JUNO
2537
PUT
DELISTED
Juno Therapeutics, Inc.
JUNO
| $769K | ﹤0.01% |
20,000
-30,000
| -60% | -$1.25M |
|
|
PTLA
2538
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $768K | ﹤0.01% |
32,526
+13,487
| +71% | +$333K |
|
|
EGL
2539
DELISTED
Engility Holdings, Inc.
EGL
| $768K | ﹤0.01% |
36,387
-10,080
| -22% | -$214K |
|
2540
BGC Group
BGC
$5.65B
| $766K | ﹤0.01% |
136,702
+88,079
| +181% | +$511K |
|
|
MOBL
2541
DELISTED
MobileIron, Inc.
MOBL
| $766K | ﹤0.01% |
251,007
-4,934
| -2% | -$17.7K |
|
2542
Omnicell
OMCL
$1.89B
| $764K | ﹤0.01% |
22,319
-2,915
| -12% | -$90.9K |
|
2543
CALL
Sarepta Therapeutics
SRPT
$1.68B
| $763K | ﹤0.01% |
40,000
| – | – |
|
|
CMA
2544
DELISTED
Comerica
CMA
| $762K | ﹤0.01% |
18,518
-270,157
| -94% | -$11.5M |
|
2545
CALL
Welltower
WELL
$175B
| $762K | ﹤0.01% |
10,000
| – | – |
|
|
SZMK
2546
DELISTED
SIZMEK INC COM STK (DE)
SZMK
| $762K | ﹤0.01% |
332,851
-10,785
| -3% | -$27.7K |
|
|
VVUS
2547
DELISTED
Vivus Inc
VVUS
| $762K | ﹤0.01% |
67,978
-41,922
| -38% | -$579K |
|
|
HSKA
2548
DELISTED
Heska Corp
HSKA
| $761K | ﹤0.01% |
20,481
+1,299
| +7% | +$43.8K |
|
2549
PUT
Electronic Arts
EA
$52.4B
| $758K | ﹤0.01% |
+10,000
| New | +$704K |
|
|
CDI
2550
DELISTED
CDI Corp.
CDI
| $758K | ﹤0.01% |
124,230
+33,814
| +37% | +$217K |
|
Similar funds
D.E. Shaw & Co's Q2 2016 Portfolio in Review
As of Q2 2016, D.E. Shaw & Co held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.
- D.E. Shaw & Co's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
- D.E. Shaw & Co added most to Amazon in Q2 2016, an estimated $549M increase.
- D.E. Shaw & Co's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
- D.E. Shaw & Co fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
- D.E. Shaw & Co opened 402 new positions and closed 445 in Q2 2016.
- D.E. Shaw & Co's portfolio value fell 2.7% quarter-over-quarter to $54.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.